Canada · Health Canada Drug Product Database
ROTARIX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 78588
- DIN
- 02300591
- Form
- Suspension
- Company as listed by source
- GLAXOSMITHKLINE INC
- Source status
- Marketed (2021-04-06)
- Source last updated
- 2025-08-06
Source-listed ingredients
- ROTAVIRUS VACCINE (RIX4414 STRAIN), LIVE, ORAL, ATTENUATED (HUMAN) — 1000000 CCID50 — per 1.5 ML
These values do not establish equivalence or a dose recommendation.
Packages
- 1ml
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →